RIAS
PCRX icon

Rachor Investment Advisory Services’s Pacira BioSciences PCRX Stock Holding History

Rachor Investment Advisory Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-120
Closed -$2.71K – 353
2026
Q1 		$2.71K Buy
120
+40
+50% +$889 ﹤0.01% 223
2025
Q4 		$2.07K Buy
+80
New +$1.9K ﹤0.01% 240

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rachor Investment Advisory Services's PCRX Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 120 shares — an estimated $2.71K sold.

Rachor Investment Advisory Services first reported a position in PCRX in Q4 2025 and held it in 2 quarters. The position peaked at $2.71K in Q1 2026. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 120 Pacira BioSciences shares in Q2 2026, an estimated $2.71K.
  • Rachor Investment Advisory Services first reported a position in Pacira BioSciences in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Pacira BioSciences position peaked at $2.71K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.